Cappella Medical Devices Ltd Announces First Enrolled Patients in Italian Sideguard(R) Study

GALWAY, Ireland--(BUSINESS WIRE)--Cappella Medical Devices announces initiation of the multi-center Italian Sideguard® open label clinical study. The Principal Investigator (PI) of the study, Dr. Giuseppe Massimo Sangiorgi at the Policlinico di Modena - University of Modena and Reggio Emilia, in Modena, Italy stated, “The side branch ostium anatomy requires a unique technology solution to effectively manage and optimize treatment. The shape and elastic properties of the nitinol Sideguard stent provide constant outward radial force on the lumen and ostium providing support and protection of the side branch over time and hopefully reducing neointimal proliferation at the ostium of the side branch in the long term follow-up. The Sideguard system is an easy-to-use solution for treating bifurcation disease and we are looking forward to being part of this study.”